Searched for
NUTRACEUTICALS
Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...- Plant-based protein market poised to reach Rs 9,000 cr in five years: Industry body PBFIAIndia's plant-based protein ingredient market is set to double to Rs 9,000 crore within five years. Consumers are shifting towards targeted...
- Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...
- AMI’s Nvidia chip bet; Groww’s new growth playHappy Wednesday! AMI has ordered 9,000 Nvidia Vera Rubin chips, becoming one of Asia’s first such adopters. This and more in today’s ETtech...
- Honasa Consumer calls off Fluence Pharma acquisitionHonasa Consumer has called off its planned acquisition of a 58% stake in nutraceuticals brand Fluence Pharma due to unmet closing condition...
- Boost for Ladakh: High-level panel to plan national sea buckthorn research hubA high-level committee will examine establishing a National Sanjeevani Research Centre for Sea Buckthorn. This initiative aims to position ...
- Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...
- Kronox Lab Sciences shares rally 32% in 2 days as Indo Borax, Zenrock Chemicals eye stake acquisitionShares of Kronox Lab Sciences surged after Indo Borax and Zenrock Chemicals announced plans to acquire a 64.26% stake in the company and la...
- Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...
- FCNR(B), nothing magical about itThe Reserve Bank of India is prematurely closing a special window for FCNR(B) bank deposits from the Indian diaspora, originally set to end...
- Chemical sector: Although long, there is a way around China trouble; combine 20 stocks to get your portfolio’s chemistry rightFor the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...
- Nutraceuticals, get it right from the startThe Indian supplements market is anticipated to soar to nearly fifty-seven billion dollars by twenty thirty, driven by heightened consumer ...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Warburg set to buy Seacod-maker Universal NutriScience for Rs 2800 croreWill be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.
- FSSAI cracks down on two firms over misleading product claims; halts sale of Folineuro Syrup, Neuherbs True VitaminIndia's food regulator FSSAI has restricted Vatave Healthcare from selling its Folineuro syrup. The company made misleading claims about im...
- Private equity firm Creador in talks to buy into generic drug co Leeford HealthPrivate equity firm Creador is in advanced talks to acquire a stake. The firm expects to invest ₹800 crore in Leeford Healthcare. This acqu...
- FSSAI cracks down on packaged water firm, health supplement makerThe FSSAI suspended Matri Drinking Water's license due to serious food safety violations. Inspection revealed improper storage and poor hyg...
- FSSAI suspends Kolkata bakery major Switz Foods' licence over unhygienic manufacturing, pest infestationIndia's food regulator has suspended Switz Foods' manufacturing licence. Serious non-compliances were found during a recent unit inspection...
- Arboreal Bioinnovations raises Rs 230 crore led by Edelweiss’s EAAA, OmnivoreSpecialty food ingredient startup Arboreal Bioinnovations has raised Rs 230 crore in a Series A funding round. This capital will fuel manuf...
- FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plantThe FSSAI has suspended Dior Pharmaceuticals' license due to serious violations. The nutraceutical factory operated with severely deficient...
Load More
